Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Change in Inventory (2017 - 2022)

Acro Biomedical has reported Change in Inventory over the past 6 years, most recently at -$296000.0 for Q4 2022.

  • Quarterly results put Change in Inventory at -$296000.0 for Q4 2022, down 166.07% from a year ago — trailing twelve months through Sep 2022 was $744000.0 (up 51.84% YoY), and the annual figure for FY2021 was $938000.0, up 1678.06%.
  • Change in Inventory for Q4 2022 was -$296000.0 at Acro Biomedical, down from $592000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for ACBM hit a ceiling of $980000.0 in Q3 2021 and a floor of -$560000.0 in Q2 2021.
  • Median Change in Inventory over the past 5 years was -$8300.0 (2018), compared with a mean of $74401.4.
  • Peak annual rise in Change in Inventory hit 113.24% in 2021, while the deepest fall reached 219.37% in 2021.
  • Acro Biomedical's Change in Inventory stood at -$86600.0 in 2018, then tumbled by 109.52% to -$181440.0 in 2019, then soared by 358.55% to $469120.0 in 2020, then dropped by 4.5% to $448000.0 in 2021, then plummeted by 166.07% to -$296000.0 in 2022.
  • The last three reported values for Change in Inventory were -$296000.0 (Q4 2022), $592000.0 (Q3 2022), and -$296000.0 (Q2 2022) per Business Quant data.